Troy Groetken is a Shareholder, Board Member, and Executive Committee member at McAndrews. He has over 28 years of legal experience in the intellectual property field and more than 30 years of technical experience in the pharmaceutical, biotechnological, and chemical fields. He is recognized in IAM’s Strategy 300: The World’s Leading IP Strategists and Patent 1000: The World’s Leading Patent Professionals, and has been listed as one of the Best Lawyers in America since 2012.

As a registered U.S. patent attorney, Troy is known globally as a “go-to” intellectual property attorney for Fortune 100 and 500 clients, which he assists on complex intellectual property matters and strategic global patent portfolio development, implementation, positioning, and enforcement. Troy also advises clients regarding the acquisition, divestiture, and licensing of core and non-core intellectual property assets. In addition, he is a thought leader with respect to patent portfolio due diligence analyses, global portfolio coordination (e.g., coordination of complex U.S. reexamination or reissue proceedings with European, Asian, and Australian appeals, cancellation, nullity, and/or opposition proceedings), and advanced U.S. Patent Office procedural issues (e.g., strategic use of inter partes review and post-grant review practice).

Troy counsels domestic and foreign clients on a broad range of technical disciplines in the chemical, pharmaceutical, and biotechnological arts. Areas include new drug entities (small-molecule, protein, recombinant, combinatorial technologies, assay, etc.), diagnostics, biological molecular technologies, API development and positioning, generic pharmaceuticals, biosimilars, pharmaceutical conjugates, vaccines, cancer therapeutics, CAR-T technologies, mRNA technologies, antibody technologies, surfactant technologies, agricultural compositions, food-based technologies, animal compositions, gellants, polyols, lubricants, coatings, elastomers, sealants, adhesives, construction products (interior and exterior), biocides, medical devices, drug delivery formulations and systems, drug storage and logistical systems, including RFID technologies, laundry and cleaning products, inorganic and organic synthesis products, pharmaceutical supplements, Big Data and artificial intelligence (within the pharmaceutical, life science, precision clinical therapy, and logistical intellectual property spaces), personal care and cosmetic formulations, oil and gas technologies, alternative fuels, fuel cells, and renewable energies, among others.

Prior to practicing patent law, Troy worked as a clinical consultant pharmacist, supervised drug research programs in coordination with the FDA, evaluated drug-management protocols, and performed drug-treatment trials on behalf of various hospitals, research institutions, and drug companies.